Treatment of Severe Acute Bacterial Keratitis in Rabbits Using Continuous Topical Ocular Instillation with Norvancomycin

References

• UngL, BispoPJM, ShanbhagSS, et al. The persistent dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial resistance. Surv Ophthalmol. 2019;64:255–271. doi:10.1016/j.survophthal.2018.12.00330590103
   PubMed Web of Science ®Google Scholar
• SongX, XieL, TanX, et al. A multi-center, cross-sectional study on the burden of infectious keratitis in China. PLoS One. 2014:9. doi:10.1371/journal.pone.0113843.
   Web of Science ®Google Scholar
• AsbellPA, SanfilippoCM, PillarCM, et al. Antibiotic resistance among ocular pathogens in the united states. JAMA Ophthalmol. 2015;133:1445. doi:10.1001/jamaophthalmol.2015.388826502312
   PubMed Web of Science ®Google Scholar
• MahFS, DavidsonR, HollandEJ, et al. Current knowledge about and recommendations for ocular methicillin-resistant Staphylococcus aureus. J Cataract Refract Surg. 2014;40:1894–1908. doi:10.1016/j.jcrs.2014.09.02325442885
   PubMed Web of Science ®Google Scholar
• DonaduM, UsaiD, PinnaA, et al. In vitro activity of hybrid lavender essential oils against multidrug resistant strains of pseudomonas aeruginosa. J Infect Dev Ctries. 2018;12:9–14. doi:10.3855/jidc.992031628828
   PubMed Web of Science ®Google Scholar
• DonaduMG, LeNT, HoDV, et al. Phytochemical compositions and biological activities of essential oils from the leaves, rhizomes and whole plant of hornstedtia bella Skorničk. Antibiotics. 2020;9:1–16. doi:10.3390/antibiotics9060334
   Web of Science ®Google Scholar
• CannasS, UsaiD, PinnaA, et al. Essential oils in ocular pathology: an experimental study. J Infect Dev Ctries. 2015;9:650–654. doi:10.3855/jidc.684226142676
   PubMed Web of Science ®Google Scholar
• LeNT, DonaduMG, HoDV, et al. Biological activities of essential oil extracted from leaves of Atalantia sessiflora Guillauminin Vietnam. J Infect Dev Ctries. 2020;14:1054–1064. doi:10.3855/JIDC.1246933031096
   PubMed Web of Science ®Google Scholar
• Chaves-LópezC, UsaiD, DonaduMG, et al. Potential of: borojoa patinoi Cuatrecasas water extract to inhibit nosocomial antibiotic resistant bacteria and cancer cell proliferation in vitro. Food Funct. 2018;9:2725–2734. doi:10.1039/c7fo01542a29658045
   PubMed Web of Science ®Google Scholar
• LinA, RheeMK, AkpekEK, et al. Bacterial keratitis preferred practice pattern®. Ophthalmology. 2019;126:P1–P55. doi:10.1016/j.ophtha.2018.10.01830366799
   PubMed Web of Science ®Google Scholar
• HenryCR, FlynnHW, MillerD, et al. Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology. 2012;119(12):2443–2449. doi:10.1016/j.ophtha.2012.06.03022858123
   PubMed Web of Science ®Google Scholar
• JinH, ParkerWT, LawNW, et al. Evolving risk factors and antibiotic sensitivity patterns for microbial keratitis at a large county hospital. Br J Ophthalmol. 2017;101(11):1483–1487. doi:10.1136/bjophthalmol-2016-31002628336675
   PubMed Web of Science ®Google Scholar
• SharmaA, TaniguchiJ. Review: emerging strategies for antimicrobial drug delivery to the ocular surface: implications for infectious keratitis. Ocul Surf. 2017;15(4):670–679. doi:10.1016/j.jtos.2017.06.00128602948
   PubMed Web of Science ®Google Scholar
• AustinA, LietmanT, Rose-NussbaumerJ. Update on the Management of Infectious Keratitis. Ophthalmology. 2017;124(11):1678–1689. doi:10.1016/j.ophtha.2017.05.01228942073
   PubMed Web of Science ®Google Scholar
• AwwadS, Mohamed AhmedAHA, SharmaG, et al. Principles of pharmacology in the eye. Br J Pharmacol. 2017;174:4205–4223. doi:10.1111/bph.1402428865239
   PubMed Web of Science ®Google Scholar
• AgrahariV, MandalA, AgrahariV, et al. A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res. 2016;6(6):735–754. doi:10.1007/s13346-016-0339-227798766
   PubMed Web of Science ®Google Scholar
• LinW, ZhaoL, HuangX, et al. Comparative assessment of distribution characteristics and ocular pharmacokinetics of norvancomycin between continuous topical ocular instillation and hourly administration of eye drop. Drug Des Devel Ther. 2020;14:867–879. doi:10.2147/DDDT.S233047
   PubMed Web of Science ®Google Scholar
• LiJ, HeS, YangZ, et al. Pharmacokinetics and cerebrospinal fluid penetration of norvancomycin in Chinese adult patients. Int J Antimicrob Agents. 2017;49:603–608. doi:10.1016/j.ijantimicag.2017.01.01428366660
   PubMed Web of Science ®Google Scholar
• WuY, KangJ, WangQ. Drug concentrations in the serum and cerebrospinal fluid of patients treated with norvancomycin after craniotomy. Eur J Clin Microbiol Infect Dis. 2017;36:305–311. doi:10.1007/s10096-016-2803-927738856
   PubMed Web of Science ®Google Scholar
• JiangZ, LeiX, ChenM, et al. Three structurally-related impurities in norvancomycin drug substance. J Antibiot (Tokyo). 2017;70:158–165. doi:10.1038/ja.2016.11527703158
   PubMed Web of Science ®Google Scholar
• DuanYQ, YangYZ, HuangXT, et al. Research on the comparison of the demethylvancomycin’s diffusion-deposition characteristics in the ocular solid tissues of sustained subtenon drug delivery with subconjunctival injection. Drug Deliv. 2017;24:92–98. doi:10.1080/10717544.2016.123090428155569
   PubMed Web of Science ®Google Scholar
• BachuR, ChowdhuryP, Al-SaediZ, et al. Ocular drug delivery barriers—role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics. 2018;10(1):28. doi:10.3390/pharmaceutics10010028
   PubMed Web of Science ®Google Scholar
• JanagamDR, WuL, LoweTL. Nanoparticles for drug delivery to the anterior segment of the eye. Adv Drug Deliv Rev. 2017;122:31–64. doi:10.1016/j.addr.2017.04.00128392306
   PubMed Web of Science ®Google Scholar
• YellepeddiVK, PalakurthiS. Recent Advances in Topical Ocular Drug Delivery. J Ocul Pharmacol Ther. 2016;32:67–82. doi:10.1089/jop.2015.004726666398
   PubMed Web of Science ®Google Scholar
• YousryC, ElkheshenSA, El-laithyHM, et al. Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery. Eur J Pharm Sci. 2017;100:142–154. doi:10.1016/j.ejps.2017.01.01328089661
   PubMed Web of Science ®Google Scholar
• BertensCJF, GijsM, van den BiggelaarFJHM, et al. Topical drug delivery devices: a review. Exp Eye Res. 2018;168:149–160. doi:10.1016/j.exer.2018.01.01029352994
   PubMed Web of Science ®Google Scholar
• AgarwalR, IezhitsaI, AgarwalP, et al. Liposomes in topical ophthalmic drug delivery: an update. Drug Deliv. 2016;23:1075–1091. doi:10.3109/10717544.2014.94333625116511
   PubMed Web of Science ®Google Scholar
• WeiS, ZhangC, ZhangS, et al. Treatment results of corneal collagen cross-linking combined with riboflavin and 440 nm blue light for bacterial corneal ulcer in rabbits. Curr Eye Res. 2017;42:1401–1406. doi:10.1080/02713683.2017.133276728644681
   PubMed Web of Science ®Google Scholar
• KalraP, AhirwarLK, MittalR, et al. Clinical and histopathological evaluation of a rabbit model for pythium insidiosum keratitis. Curr Eye Res. 2020:1–8. doi:10.1080/02713683.2019.1676911
   Web of Science ®Google Scholar
• ZaidiT, ReidyT, D’OrtonaS, et al. CD74 deficiency ameliorates Pseudomonas aeruginosa-induced ocular infection. Sci Rep. 2011;1:1–7. doi:10.1038/srep0005822355520
   PubMed Web of Science ®Google Scholar
• ShiY, LvH, FuY, et al. Preparation and characterization of a hydrogel carrier to deliver gatifloxacin and its application as a therapeutic contact lens for bacterial keratitis therapy. Biomed Mater. 2013:8. doi:10.1088/1748-6041/8/5/055007.
   Web of Science ®Google Scholar
• TasT, KucukbayrakA, HakyemezIN, et al. Linezolid versus vancomycin for the treatment of methicillin-resistant staphylococcus aureus keratitis in rabbits. Cornea. 2013;32:1052–1057. doi:10.1097/ICO.0b013e3182912ffa23665649
   PubMed Web of Science ®Google Scholar
• BhartiSK, KesavanK. Phase-transition W/O Microemulsions for Ocular Delivery: evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis. Ocul Immunol Inflamm. 2017;25:463–474. doi:10.3109/09273948.2016.113913626943481
   PubMed Web of Science ®Google Scholar
• WangM, SmithWA, DuncanJK, et al. Treatment of Pseudomonas keratitis by continuous infusion of topical antibiotics with the Morgan Lens. Cornea. 2017;36:617–620. doi:10.1097/ICO.000000000000112828002114
   PubMed Web of Science ®Google Scholar
• KesavanK, KantS, PanditJK. Therapeutic effectiveness in the treatment of experimental bacterial keratitis with ion-activated mucoadhesive Hydrogel. Ocul Immunol Inflamm. 2016;24:489–492. doi:10.3109/09273948.2015.100523826133969
   PubMed Web of Science ®Google Scholar
• Alvarez-LorenzoC, Anguiano-IgeaS, Varela-GarcíaA, et al. Bioinspired hydrogels for drug-eluting contact lenses. Acta Biomater. 2019;84:49–62. doi:10.1016/j.actbio.2018.11.02030448434
   PubMed Web of Science ®Google Scholar
• PinnaA, DonaduMG, UsaiD, et al. In vitro antimicrobial activity of a new ophthalmic solution containing povidone-iodine 0.6% (IODIM®). Acta Ophthalmol. 2020;98:e178–e180. doi:10.1111/aos.1424331486592
   PubMed Web of Science ®Google Scholar
• PinnaA, DonaduMG, UsaiD, et al. In vitro antimicrobial activity of a new ophthalmic solution containing hexamidine diisethionate 0.05% (keratosept). Cornea. 2020;39:1415–1418. doi:10.1097/ICO.000000000000237532452982
   PubMed Web of Science ®Google Scholar
• ChouhanS, SharmaK, GuleriaS. Antimicrobial activity of some essential oils-present status and future perspectives. Medicine. 2017;4:58. doi:10.3390/medicines4030058
   Google Scholar